Intralesional Bleomycin in Lymphangioma: An Effective and Safe Non-Operative Modality of Treatment

@inproceedings{Kumar2012IntralesionalBI,
  title={Intralesional Bleomycin in Lymphangioma: An Effective and Safe Non-Operative Modality of Treatment},
  author={Vijayendra Kumar and Pankaj Kumar and Anand Pandey and Deepak Kumar Gupta and Ram Chandra Shukla and Shiv Prasad Sharma and Ajay Narayan Gangopadhyay},
  booktitle={Journal of cutaneous and aesthetic surgery},
  year={2012}
}
INTRODUCTION Lymphangiomas are benign hamartomatous lymphatic tumors. The mainstay of the therapy is surgical excision, but due to its infiltration along the nerves and muscles, total excision is not always possible. In the present study, we have evaluated the clinical profile of all the cases of lymphagiomas coming to our department and evaluated the efficacy of intralesional Bleomycin as a sclerosing agent in its management. MATERIALS AND METHODS In this prospective study, all patients were… CONTINUE READING
6 Citations
18 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Handbook of Dermatologic Drug Therapy

  • SR Feldman, KC Phelps, KC. Verzino
  • 2005
1 Excerpt

Bleomycin as intralesional sclerosant for cystic hygromas

  • JK Mahajan, V Bharathi, SK Chowdhary, R Samujh, P Menon, KL. Rao
  • J Indian Assoc Pediatr Surg 2004;9:3-7
  • 2004
1 Excerpt

Treatment options for the management of vascular malformations

  • M Waner, JY Suen
  • Hemangiomas and vascular malformations of the…
  • 1999
1 Excerpt

Similar Papers

Loading similar papers…